Multiple sclerosis in diverse populations: Characteristics in distinct Arab ethnicities in Israel

Multiple Sclerosis Journal

Volumn 18, Issue 12, 2012, Pages 1737-1744

  Siegel, Michal ^a   Paperna, Tamar ^a   Lejbkowicz, Izabella ^a   Petrou, Panayiota ^b   Shahien, Radi ^c   Karussis, Dimitrios ^b   Lavi, Idit ^d   Dishon, Sara ^d   Rawashdeh, Hanna ^d   Miller, Ariel ^a,d  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c Sieff Medical Center   (Israel)

^d CARMEL MEDICAL CENTER   (Israel)

Author keywords

Autoimmune disease; disease course; epidemiology; multiple sclerosis; natural history studies (prognosis); population characteristics

Indexed keywords

ADULT; ARAB; ARTICLE; CHRISTIAN; COHORT ANALYSIS; DISEASE COURSE; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; HUMAN; ISRAEL; JEW; MAJOR CLINICAL STUDY; MALE; MOSLEM; MULTIPLE SCLEROSIS; POPULATION RESEARCH;

EID: 84871538606     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512445059     Document Type: Article

References (33)

1. Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010 ; 9: 520-532
2. Kister I, Chamot E, Bacon JH, et al. Rapid disease course in African Americans with multiple sclerosis. Neurology. 2010 ; 75: 217-223
3. Cree BA, Khan O, Bourdette D, et al. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology. 2004 ; 63: 2039-2045
4. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol. 2003 ; 2: 117-127
5. Coyle PK. Early treatment of multiple sclerosis to prevent neurologic damage. Neurology. 2008 ; 71: S3 - S7
6. Central Bureau of Statistics SoI. Statistical Abstract of Israel 2010, http://www.cbs.gov.il/reader/shnaton/templ-shnaton-e.html?num-tab= st02-02&CYear=2010 (2010, accessed 13 May 2011).
7. Central Bureau of Statistics SoI. The Arab Population in Israel, http://www.cbs.gov.il/www/statistical/arab-pop08e.pdf (2008, accessed 28 March 2011).
8. Alter M, Kahana E, Zilber N, et al. Multiple sclerosis frequency in Israel's diverse populations. Neurology. 2006 ; 66: 1061-1066
9. Benamer HT, Ahmed ES, Al-Din AS, et al. Frequency and clinical patterns of multiple sclerosis in Arab countries: A systematic review. J Neurol Sci. 2009 ; 278: 1-4
10. Yamout B, Barada W, Tohme RA, et al. Clinical characteristics of multiple sclerosis in Lebanon. J Neurol Sci. 2008 ; 270: 88-93
11. Al-Araji A, Mohammed AI. Multiple sclerosis in Iraq: Does it have the same features encountered in Western countries?. J Neurol Sci. 2005 ; 234: 67-71
12. El-Salem K, Al-Shimmery E, Horany K, et al. Multiple sclerosis in Jordan: A clinical and epidemiological study. J Neurol. 2006 ; 253: 1210-1216
13. Al-Din AS. Multiple sclerosis in Kuwait: Clinical and epidemiological study. J Neurol Neurosurg Psychiatry. 1986 ; 49: 928-931
14. Zalloua PA, Xue Y, Khalife J, et al. Y-chromosomal diversity in Lebanon is structured by recent historical events. Am J Hum Genet. 2008 ; 82: 873-882
15. Shlush LI, Behar DM, Yudkovsky G, et al. The Druze: A population genetic refugium of the Near East. PLoS One. 2008 ; 3: e2105
16. Zlotogora J. The molecular basis of autosomal recessive diseases among the Arabs and Druze in Israel. Hum Genet. 2010 ; 128: 473-479
17. Benedek G, Paperna T, Avidan N, et al. Opposing effects of the HLA-DRB1*0301-DQB1*0201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel. Genes Immun. 2010 ; 11: 423-431
18. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001 ; 50: 121-127
19. Poser CM, Brinar VV. Diagnostic criteria for multiple sclerosis. Clin Neurol Neurosurg. 2001 ; 103: 1-11
20. Central Bureau of Statistics SoI. Israeli Settlements, http://www.cbs.gov.il/ishuvim/ishuvim-main.htm. (2009, accessed 4 April 2011).
21. Disanto G, Berlanga AJ, Handel AE, et al. Heterogeneity in multiple sclerosis: Scratching the surface of a complex disease. Autoimmune Dis. 2011 ; 2011: 932351
22. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996 ; 46: 907-911
23. Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain. 2003 ; 126: 770-782
24. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology. 1983 ; 33: 1444-1452
25. Roxburgh RH, Seaman SR, Masterman T, et al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology. 2005 ; 64: 1144-1151
26. Vardi-Saliternik R, Friedlander Y, Cohen T. Consanguinity in a population sample of Israeli Muslim Arabs, Christian Arabs and Druze. Ann Hum Biol. 2002 ; 29: 422-431
27. Handel AE, Giovannoni G, Ebers GC, et al. Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol. 2010 ; 6: 156-166
28. Langer-Gould A, Popat RA, Huang SM, et al. Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: A systematic review. Arch Neurol. 2006 ; 63: 1686-1691
29. Weiner HL. The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease?. Ann Neurol. 2009 ; 65: 239-248
30. Inshasi J, Thakre M. Prevalence of multiple sclerosis in Dubai, United Arab Emirates. Int J Neurosci. 2011 ; 121: 393-398
31. Marrie RA, Cutter G, Tyry T, et al. Does multiple sclerosis-associated disability differ between races?. Neurology. 2006 ; 66: 1235-1240
32. Yosef AR. Health beliefs, practice, and priorities for health care of Arab Muslims in the United States. J Transcult Nurs. 2008 ; 19: 284-291
33. Elnekave E, Gross R. The healthcare experiences of Arab Israeli women in a reformed healthcare system. Health Policy. 2004 ; 69: 101-116